Home
Mayer Brown
GenevièVe Michaux
GenevièVe Michaux
Mayer Brown
New EU Regulation Extends Financial Penalties To Entities Beyond The Marketing Authorization Holder And Updates The Legal Framework For Medicinal Products For Human Use
04 Feb 2019 | European Union
Europe—New Regulation (EU) 2019/5 Extends Financial Penalties To Entities Beyond The Marketing Authorization Holder And Updates The Legal Framework For Medicinal Products For Human Use
04 Feb 2019 | European Union
Europe—General Court Confirms Obligation To Prove Significant Benefit Over All Authorized Medicinal Products, Including Those Authorized After The Submission Of The Marketing Authorization Application For The Future (Orphan) Product
13 Dec 2018 | European Union
Europe—Brexit Alert on Cosmetic Products
07 Dec 2018 | European Union
European Commission's Update Of Guideline On Duplicate Marketing Authorizations To Cover Biosimilars
31 May 2018 | European Union
Europe—Key Dates And Roadmap For Implementation Of New Rules On Medical Devices
04 Dec 2017 | European Union
Europe—The Draft New Definition Of "Similarity" For Orphan Products Is Out For Public Consultation Again
07 Nov 2017 | European Union
European Commission Issues Notice On Brexit's Implications For Pharmaceutical Companies
11 May 2017 | UK
European Commission Publishes Revised Guidelines On Criteria For Orphan Designations Of Medicinal Products
12 Jan 2017 | European Union
European Commission Publishes Revised Guideline On Criteria For Orphan Designation Of Medicinal Products
05 Dec 2016 | European Union
Contact Details
London
Email Website
London
UK

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.